David Lacey will have more time to bicycle along the Central Coast and sip a little wine. But don’t expect Amgen Inc.’s soon-to-retire discovery research chief and South San Francisco site head to get lost on the backroads.
A little more than a year ago, the 58-year-old Lacey started talking to Roger Perlmutter, Amgen’s executive vice president of research and development, more seriously about retiring.
“There are things I want to do, and with the dispersion of this job, you’re share of mind has got to be 100 percent on what the job is,” Lacey said.
But all good bicyclists on a long ride take care to map their routes in advance — with a little wiggle room for exploration — and Lacey is no exception.